The present stock price for Amicus Therapeutics Inc (FOLD) is $7.6. In the last trading session, the stock made a considerable jump, reaching $22.0 after an opening price of $7.6. The stock briefly fell to $9.0 before ending the session at $7.4.
Amicus Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $12.65 on 11/06/24, while the lowest price for the same duration was marked at $5.51 on 06/25/25.
52-week price history of FOLD Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Amicus Therapeutics Inc’s current trading price is -39.92% away from its 52-week high, while its distance from the 52-week low is 37.93%. The stock’s price range during this period has spanned from $5.51 to $12.65. In the Healthcare sector, the Amicus Therapeutics Inc’s shares surpassed a trading volume of approximately 3.42 million for the day, which was noticeably lower compared to the average daily volume of 9.4.66 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Amicus Therapeutics Inc (FOLD) has experienced a quarterly rise of 19.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.34B and boasts a workforce of 499 employees.
A Closer Look at Analysts’ Ratings for Amicus Therapeutics Inc
As of right now, 8 analysts are rating Amicus Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.49, with a change in price of -0.83. Similarly, Amicus Therapeutics Inc recorded 4,746,881 in trading volume during the last 100 days, posting a change of -9.85%.
Examining FOLD’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for FOLD stands at 2.17. Similarly, the long-term debt-to-equity ratio is also 2.13.
FOLD Stock Stochastic Average
Today, Amicus Therapeutics Inc’s raw stochastic average for the past 50 days stands at 98.12%, indicating a rise from the raw stochastic average of the last 20 days, which was 97.67%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 93.33% and 93.07% respectively.
FOLD Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -36.08% this year. Over the last six months, there has been a stronger performance of -16.21%. The price of FOLD fallen by 20.44% during the last 30 days period. For the last 5-days stocks have improved 6.74%.
